Sunshine Biopharma Inc (NASDAQ:SBFM) has a beta value of 0.38 and has seen 19873.0 shares traded in the last trading session. The company, currently valued at $5.63M, closed the last trade at $2.08 per share which meant it gained $0.17 on the day or 8.90% during that session. The SBFM stock price is -12640.38% off its 52-week high price of $265.00 and 8.65% above the 52-week low of $1.90. If we look at the company’s 10-day average daily trading volume, we find that it stood at 71850.0 shares traded. The 3-month trading volume is 66.12K shares.

Sunshine Biopharma Inc (NASDAQ:SBFM) trade information

Sporting 8.90% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SBFM stock price touched $2.08 or saw a rise of 5.88%. Year-to-date, Sunshine Biopharma Inc shares have moved -30.67%, while the 5-day performance has seen it change -2.35%. Over the past 30 days, the shares of Sunshine Biopharma Inc (NASDAQ:SBFM) have changed -9.96%. Short interest in the company has seen 0.11 million shares shorted with days to cover at 2.4.

Sunshine Biopharma Inc (SBFM) estimates and forecasts

The company’s shares have lost -35.00% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 73.50% over the past 5 years.

SBFM Dividends

Sunshine Biopharma Inc is expected to release its next earnings report on 2024-Nov-04 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Sunshine Biopharma Inc (NASDAQ:SBFM)’s Major holders

Insiders own 7.22% of the company shares, while shares held by institutions stand at 1.12% with a share float percentage of 1.21%. Investors are also buoyed by the number of investors in a company, with Sunshine Biopharma Inc having a total of 14.0 institutions that hold shares in the company.